Back

We are pleased to announce that Schlich has been ranked as a recommended UK firm for patent filings in 2023 by JUVE. Schlich is one of just 25 firms to be recommended, selected for our work in the fields of Medical Technology as well as Pharma and Biotechnology.

Schlich has in particular been noticed for our work on patent filings for some of our well known clients such as AbbVie, Dimension Genomics, Fred Hutchinson Cancer Center, ONK Therapeutics, Vector Vitale, as well as a number of US universities.

Our litigation work in oppositions before the EPO was also highlighted, with notable mentions made to our work on behalf of Intellia Therapeutics in the opposition proceedings over CRISPR-Cas patents against The Broad Institute, Sigma-Aldrich and Toolgen, together with our representation of Glenmark against Towa over the formulation of dabigatran. A further mention was made to our strawman suits for medical devices against Cook Medical, and for Parkinson’s and Alzheimer’s therapy against Centre National de la Recherche Scientifique.

JUVE Patent is an online research tool for the European patent market. It produces rankings of firms in the four main patent jurisdictions in Europe; France, Germany, the UK and the Netherlands; as well as Austria.

We are delighted to have been selected from, and ranked among many prestigious and sizeable firms, a sign of Schlich’s growing success!


Our articles are for general information only. They should not be considered specific legal advice, which is available upon request. All information in our articles is considered to be accurate at the date of publishing.

Latest Firm News

Schlich Walks for Mental Health Awareness Week

Schlich Walks for Mental Health Awareness Week

With the sun making an appearance and this week being Mental Health Awareness Week we have swapped our treadmill team effort and decided to join the ‘2024 Mental Health – Moving More Challenge’ by taking ourselves away from our desks and walking along the seafront during our lunch breaks. 

read more
Simon Wright featured on epi’s first podcast

Simon Wright featured on epi’s first podcast

‘Insight epi’, the epi’s first podcast series, was launched earlier last month to discuss topics of interest in the patent profession. The series premiered with Schlich’s own Simon Wright joining the discussion on the patenting and development of new plants and ‘new genetic techniques’.  

read more